The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Menopause evaluation and treatment

Menopause evaluation and treatment — individualized management of hot flashes, sleep disturbance, and long-term health risks.

Long-term women's health management during the menopausal period (when menstruation has permanently stopped), in which vasomotor complaints, urogenital atrophy, and bone and cardiovascular risks are evaluated and either hormone replacement therapy (HRT) or non-hormonal options are planned according to an individualized risk-benefit balance.

Indication

  • Hot flashes, night sweats, and sleep disturbances (vasomotor symptoms)
  • Vaginal dryness, painful intercourse, and urinary complaints (urogenital atrophy)
  • Management of irregular periods and bleeding during the premenopausal and perimenopausal stages
  • Early menopause (before age 40) or premature ovarian insufficiency
  • Hormonal evaluation after surgical menopause (removal of the ovaries)
  • Bone-mineral density (BMD) evaluation for osteoporosis risk
  • Mood changes, difficulty with concentration, and decreased sexual desire

Preparation

  • Prepare a menstrual history, the date of the last period, and family history
  • Note current medications, smoking, and alcohol use
  • Bring previous breast, uterine, and ovarian evaluations
  • Come fasting for blood pressure, blood sugar, cholesterol, and liver function follow-up if needed
  • Verify that mammography and Pap smear screening are up to date

How it's performed

  1. Detailed history-taking and symptom assessment (a symptom score may be used)
  2. Pelvic examination and, when needed, transvaginal ultrasound for evaluation of the uterus and ovaries
  3. Blood tests including FSH, estradiol, thyroid function tests, and lipid profile
  4. Bone-mineral density (DXA) and cardiovascular risk assessment are planned
  5. Hormone replacement therapy (HRT) risk-benefit profile is evaluated individually
  6. Non-hormonal options (SSRIs, gabapentin, clonidine, local estrogen, lifestyle recommendations) are discussed

Post-procedure

  • If HRT is started, side-effect and effectiveness review at month 3
  • Annual breast, uterine, and cardiovascular check for patients on therapy
  • Early consultation if irregular bleeding or new symptoms occur
  • Calcium, vitamin D, and exercise recommendations for bone health
  • Treatment duration and dosage are reassessed at regular intervals

Risks

  • Small increase in the risk of breast cancer, deep vein thrombosis, and stroke with hormone therapy
  • Risk of endometrial cancer with unopposed estrogen in women with an intact uterus
  • Side effects such as breast tenderness, headache, nausea, and irregular bleeding
  • Drowsiness, dry mouth, and changes in sexual function with non-hormonal treatments
  • Long-term risks of treatments started or extended without proper evaluation

FAQ

Is hormone therapy (HRT) safe?

In healthy women under 60 or within the first 10 years of menopause, short- to medium-term use generally provides more benefit than risk. The decision is individualized based on each patient's risk factors. It is evaluated more carefully in patients with a history of breast cancer, cardiovascular disease, or thrombosis.

Should every woman take hormones during menopause?

No. HRT is primarily considered in patients with moderate-to-severe vasomotor symptoms, early menopause, or osteoporosis risk. For mild symptoms, lifestyle adjustments and non-hormonal options may be sufficient.

Can menopausal symptoms be reduced without hormones?

Yes. Regular exercise, weight control, smoking cessation, reducing caffeine and alcohol, soy products, SSRIs/SNRIs, gabapentin, local estrogen creams, and behavioral therapies can all be effective.

Is pregnancy possible after menopause?

Spontaneous pregnancy is not expected after menopause. However, the chance of pregnancy in the perimenopausal period is not zero; contraception should be continued for one year. Assisted reproduction with donor eggs is a separate matter.